Clinical Assistant Professor, Division of Nuclear Medicine, Department of Radiology.
Radiology Resident, Department of Radiology, University of North Carolina-Chapel Hill, Chapel Hill, NC.
Obstet Gynecol Surv. 2016 Sep;71(9):545-56. doi: 10.1097/OGX.0000000000000345.
Positron emission tomography/Computed tomography(PET/CT) is widely used for gynecologic cancers.
To determine when PET/CT should be used for gynecologic cancers.
PubMed was reviewed for articles on PET/CT of all gynecologic cancers. National Comprehensive Cancer Network, Society of Gynecologic Oncology, and American College of Radiology guidelines were reviewed.
Whole-body PET/CT is useful for (1) initial staging of cervical and endometrial cancer, posttherapy assessment, radiation therapy planning, and posttreatment surveillance of cervical cancer, and (2) assessment of recurrence of cervical, endometrial, or ovarian cancer in the presence of symptoms. It is also useful for staging and recurrence of uterine sarcomas, and for staging of vulvar and vaginal cancer.
Positron emission tomography/Computed tomography is clinically valuable for a variety of gynecologic cancers.
PET/CT plays an important role in detection of initial disease and recurrence of gynecologic malignancies.
正电子发射断层扫描/计算机断层扫描（PET/CT）广泛用于妇科癌症。
确定何时应将 PET/CT 用于妇科癌症。
对所有妇科癌症的 PET/CT 进行了 PubMed 检索。审查了美国国家综合癌症网络、妇科肿瘤学会和美国放射学院的指南。
全身 PET/CT 对以下情况有用：（1）子宫颈癌和子宫内膜癌的初始分期、治疗后评估、放疗计划和宫颈癌的治疗后监测；（2）在有症状的情况下评估子宫颈、子宫内膜或卵巢癌的复发情况。它还可用于评估子宫肉瘤的分期和复发情况，以及外阴和阴道癌的分期。
正电子发射断层扫描/计算机断层扫描在各种妇科癌症的诊断中具有重要的临床价值。
PET/CT 在检测妇科恶性肿瘤的初始疾病和复发方面发挥着重要作用。
